← Back to Search

Imaging

Imaging Techniques for Urologic Cancers

N/A

Recruiting

Led By Matthew Mossanen, MD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects must be scheduled to undergo a laparoscopic lymph node dissection and/or a urologic organ removal within any OR at BWH

Subjects aged ≥ 18 years with a confirmed or suspected diagnosis of disease in urologic regions of interest, with scheduled confirmatory surgical biopsy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial aims to improve surgical outcomes in cancer patients, reducing complications and improving accuracy of visualization and localization.

Who is the study for?

This trial is for adults over 18 with suspected or confirmed urologic cancers (like prostate, bladder, kidney, testicular, penile, urethral) who are scheduled for surgical biopsy or organ removal. They must have had a CT/PET/MR scan at Brigham and Women's Hospital within the last year and be able to undergo laparoscopic surgery.Check my eligibility

What is being tested?

The study tests if using electromagnetic tracking with laparoscope imaging and ultrasound can improve the accuracy of locating diseased areas during lymph node dissections or organ removals in urologic cancer surgeries. It aims to enhance outcomes and reduce complications.See study design

What are the potential side effects?

While not drug-related, potential side effects may include typical risks associated with laparoscopic procedures such as infection, bleeding, pain at the incision site(s), possible damage to surrounding organs/tissues and reactions to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for a laparoscopic surgery to remove lymph nodes or a urologic organ at BWH.

Select...

I am over 18 and have a possible diagnosis needing a biopsy in my urinary system.

Select...

I am scheduled for surgery to remove lymph nodes or organs due to urologic cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Electromagnetic Tracking Data

Laparoscope Images

Ultrasound Images

Secondary outcome measures

Retrospective navigation accuracy

Trial Design

1Treatment groups

Experimental Treatment

Group I: Electromagnetic Guided Laparoscopy + UltrasoundExperimental Treatment2 Interventions

This trial will investigate the use of the novel imaging protocol patients who have a confirmed cancer diagnosis in any of the following urologic regions or organs: Bladder, Prostate, Testicle, Ureter, Kidney, Urethra, Penis, and Scrotum. - This research study involves the use of a standard of care laparoscope and ultrasound probe. The laparoscope and ultrasound probe will have an electromagnetic sensor attached which will assist in the tracking of lymph nodes of interest or organs of interest. It is expected that the entire time to record the data will be less than 10 minutes. standard of care laparoscope and ultrasound probe

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Ultrasound

2013

Completed Phase 1

~1950

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,967 Total Patients Enrolled

Siemens Medical SolutionsIndustry Sponsor

24 Previous Clinical Trials

3,718 Total Patients Enrolled

Matthew Mossanen, MDPrincipal InvestigatorBrigham and Women's Hospital

1 Previous Clinical Trials

20 Total Patients Enrolled

Media Library

Electromagnetic Guided Laparoscopy (Imaging) Clinical Trial Eligibility Overview. Trial Name: NCT05899361 — N/A

Urologic Cancers Research Study Groups: Electromagnetic Guided Laparoscopy + Ultrasound

Urologic Cancers Clinical Trial 2023: Electromagnetic Guided Laparoscopy Highlights & Side Effects. Trial Name: NCT05899361 — N/A

Electromagnetic Guided Laparoscopy (Imaging) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05899361 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots available for new participants in this experiment?

"Per the clinicaltrials.gov page, this research is not presently recruiting patients; it was originally posted on August 30th 2023 and last updated June 8th 2023. Nevertheless, there are over two thousand one hundred twenty-one other trials seeking participants at present times."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Matthew Mossanen, MD 2023. "A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05899361.

All > Testicular Cancer